ADHERIUM LIMITED — Share Issue/Capital Change 2016

Aug 11, 2016

Pages (inc this Page) 1

==> picture [191 x 53] intentionally omitted <==

12 August 2016

ASX Market Announcements ASX Limited Level 4 North Tower, Rialto 525 Collins Street Melbourne VIC 3000

RE: Release of Restricted Securities from Escrow

In connection with the quotation of Adherium Limited’s fully paid ordinary shares ( Shares ) on the Australian Securities Exchange ( ASX ) on 26 August 2015 certain security holders in the Company were required to enter into ASX imposed restriction agreements and/or voluntary escrow agreements. These agreements restricted the relevant security holders from dealing in their securities for periods of up to 24 months from the date of quotation.

In accordance with ASX Listing Rule 3.10A, the Company advises that 24,924,886 fully paid ordinary shares of the Company will be released from voluntary escrow on 26 August 2016. These shares are already quoted on the ASX.

Kind regards

==> picture [71 x 44] intentionally omitted <==

Rob Turnbull CFO & Joint Company Secretary

ASX: ADR

ABN

24 605 352 510

Company Overview

Adherium is a global leader in digital health technologies which address sub optimal medication use in chronic disease.

Directors

Dr J Doug Wilson (Chair) Mr Garth Sutherland (Group CEO) Prof John Mills Mr Jeremy Curnock Cook Mr Bruce McHarrie Mr Bryan Mogridge Dr Bill Hunter

Joint Company Secretaries

Mr Rob Turnbull Mr Mark Licciardo

Registered Office BDO L14, 140 William Street Melbourne Australia

NZ Office

Level 2, 204 Quay Street Auckland 1010 New Zealand

Email

investors@adherium.com

Websites

www.adherium.com www.smartinhaler.com

ADHERIUM LTD WWW.ADHERIUM.COM | WWW.SMARTINHALER.COM